PACS Group Reports 39.9% Revenue Growth to $1.31 Billion in Latest Quarter

PACS Group, Inc. reported significant financial improvements in its latest quarterly filing, with total revenue reaching $1.31 billion for the three months ended June 30, 2025, a 39.9% increase from $935.7 million in the same period last year. The company's patient and resident service revenue, which constitutes the majority of its income, rose to $1.31 billion, driven by a 28.3% increase in patient days and a 31.6% increase in operational beds. The net income for the quarter was $50.97 million, a substantial recovery from a net loss of $31.88 million in the prior year, reflecting a significant turnaround in profitability.

In comparison to the previous fiscal period, PACS Group's operating expenses also increased, but at a slower rate than revenue, rising 26.3% to $1.23 billion. This increase was primarily attributed to higher costs associated with salaries and wages, which surged by $168.6 million, reflecting the company's expansion from 220 to 316 facilities over the year. The general and administrative expenses decreased by 26.6% to $100.3 million, largely due to a reduction in stock-based compensation expenses from the previous year.

Strategically, PACS Group has continued to expand its operations, adding three new facilities during the first half of 2025, which contributed 119 skilled nursing beds and 175 assisted living beds. The company has also divested one facility, maintaining a focus on optimizing its portfolio. As of June 30, 2025, PACS Group operated 316 healthcare facilities across 17 states, serving over 30,500 patients daily. The company’s average occupancy rate across all facilities was 88.6%, down from 91.0% in the previous year, with mature facilities showing a slight increase in occupancy.

The filing also highlighted ongoing challenges, including a material weakness in internal controls over financial reporting, which the company is actively addressing. Additionally, PACS Group is currently in a state of forbearance with its lenders regarding its Amended and Restated Credit Facility, which has restricted its ability to borrow additional funds. Despite these challenges, the company remains optimistic about its growth trajectory, supported by a favorable reimbursement environment and a strategic focus on acquiring underperforming facilities to enhance operational performance.

Looking ahead, PACS Group anticipates continued revenue growth driven by its acquisition strategy and operational improvements. The company expects to leverage its recent expansions and operational efficiencies to enhance profitability, while also navigating the complexities of regulatory compliance and market conditions.